0.01
10-cell decrease
10-eo-cfu increase
15-ml/min
229 ml
24-hour brachial systolic pressure
8-fluo-camp binding
90-day mortality
95% confidence interval
aan stage heart failure
aanemia in patients with heart disease
aanrial fibrillation
abd classification
abnormal body composition
abnormal ca(2+) handling
abnormal cardiac t2
abnormal hr variability
abnormal liver texture changes
abnormal scn5a mrna splicing
absolute risk
absorption function
acetylcholinesterase inhibitor pyridostigmine
acquired heart failure
acs problems
acs procedures
activated neurohormonal systems
activated t cells
activating myocardial pde2
activators
active individuals
activity
acute and outpatient settings
acute autonomic nervous system modulation
acute decompensated hf
acute heart failure clinical trials
acute heart failure complicating precapillary pulmonary hypertension
acute heart failure trial
acute hf trials
acute pulmonary embolism
acute rv decompensation
acute treatment
ad-c
ad-flk
ad-flk rats
adaptive
adenoviral vector
adenyl cyclase
adherence to prescribed therapy
adjunctive treatment
adjusted hazard ratios
adjusted means
adjusted median rate ratio
adjuvant setting
administratie databases
admission median bnp levels
admission nt-probnp
admission to discharge
advanced chronic obstructive pulmonary disease
advanced copd
advanced heart failure
advanced heart failure therapy
advanced human hf
advances in treatment
adverse cardiovascular
adverse event rates
aerobic
aerobic capacity
aerobic exercise
aerobic exercise training
aerobic training
af patients
af type
af-free probability
afterload burden
age- and sex-adjusted risk
aggressive dose uptitration
aggressive medical treatment
aggressive protocols
aging
aim
air pollution
akt
albumin level
albumin levels
alcohol related
aldactone evaluation study
aldosterone antagonist eplerenone
aldosterone antagonist therapy
alendronate- etidronate-
algorithms
all-cause
all-cause medical hospitalization
allopurinol rats
alphalisa immunoassays
alphalisa® immunoassays
altered protein kinase
ambient air pollution
ambulatory heart failure trial
ambulatory icd patients
ambulatory patients
america college of physicians
american heart association guidelines on evaluation
ami mortality rates
ami patient
amyloidotic pattern
anemia treatment
ang ii infusion mouse model
angiotensin ii infusion
angiotensin receptor antagonist valsartan
angiotensin-receptor
ann arbor veterans affairs hf clinic
annular size reduction
ans mice
antagomir evoked spontaneous cardiac dysfunction
anterior leaflet opening
anthracycline metabolism
anthracycline-containing chemotherapy
anthracycline-related congestive heart failure
anthracycline-treated breast cancer patients
antiadrenergic therapeutic strategy
antiarrhythmic medication
antibodies targeting nonglycosylated
antibodies targeting the extreme n
aortic blood flow
aortic pressure curve
aortic valve oversewing
aortic valve procedures
aortic valve repairs
aortic valve surgery
apical
apical rotation
appendicular lean mass index
arg16/ gln27
aric hf model
arrhythmia substrate
arrhythmia-related costs
arterial compliance
arterial tonometry study
associated treatment strategie
asymptomatic pediatric fontan
atheromatous coronary disease
atherosclerosis risk
atp demand
atrial fibrillation/flutter
atrial structure
attention control
augmented cyclic guanosine monophosphate
augmented feedback
autonomic modulation
b act via activation of vegf pathway
b on cardiac function
b treatment
b-treated
b-type natriuretic peptide levels
band of activated caspase
barriers
basal rotations
baseline glomerular filtration rate
baseline hgb
baseline hrqol
bat n-terminal pro-brain natriuretic peptide
bb therapy
bcl-2 mrna expression
bcl-2 proteins
beagle dogs
beat-to-beat qt interval
behavioural-change interventions
best quintile of performance
bet bromodomain-containing protein 4
bet family bromodomain proteins
bet inhibition suppresses a pathological cardiac gene expression programme
beta-blocker dose
beta-blocker therapy
bhlh transcription factor hand2
bioc
bioinformatic analysis
biomarker approach to predict heart failure risk
biomarker studies
biomarker-guided clinical trial
biomarker-guided clinical trials
biomedical reasons
biomedical treatment
bisphosphonate users
bivp setting
black ethnicity
black patients
black race
blacks
blinded core laboratory
blood pressure control
blood work drawn
blunted cardiac β-ar responsiveness
blunts beta-adrenergic responses
bnp levels
bnp measurements
body composition
body fat distribution
body mass
bone morphogenetic protein
bottleneck stent model
bradycardia induced
brd4)
breast cancer patients
breath-holding
breathing control
bridge to recovery in infarction-related refractory right heart failure
bridging therapy
bromodomain inhibition halts heart failure
bundle branch block electrical activation
burden of heart failure hospitalizations
c d hf
c gmp
c-kit+ cell differentiation
c-kit+ cell phenotype
c-kit+ cell yield
c-terminally processed forms
c57bl/6 male mice
c=24.3
ca(2+) influx
ca(2+)-uptake
cachectic heart failure patients
calcineurin/nfat signalling
calf muscle
california office of statewide healthplanning and development patient discharge data
caloric restriction
camp hydrolysis mediating a negative cross talk
camp hydrolytic activity
camp levels
camp production
camp-dependent protein kinase
cancer
candesartan in heart failure assessment
canine model
cardiac autonomic balance
cardiac benign tumors
cardiac c-kit+ cells
cardiac comorbidities
cardiac diameters
cardiac energy metabolism
cardiac explant c-kit+ progenitors
cardiac explant-derived cells
cardiac gene control
cardiac genes
cardiac hypertrophic response
cardiac hypertrophy secondary to pressure-overload
cardiac insulin-resistance
cardiac irs1
cardiac magnetic resonance postcontrast
cardiac magnetic resonance t1 mapping
cardiac mena deletion
cardiac mrna levels
cardiac myocyte-specific mena overexpression
cardiac na+ current
cardiac nurses
cardiac pathophysiology
cardiac patients
cardiac performance
cardiac plasma membrane levels
cardiac procedures
cardiac resynchronization
cardiac sodium current
cardiac specialty hospital
cardiac sympathetic tone
cardiac symptoms
cardiac tissue
cardiac transplant recipients
cardiac transplant survival
cardiac vagal
cardiac vagal tone
cardio failure
cardiologist
cardiology practices participating in the national cardiovascular disease registry practice innovation
cardiology services
cardiology-cardiovascular surgery consensus report heart failure
cardiomyocyte-like cells
cardiomyopathic restriction
cardiomyopathy origin
cardioprotective effect
cardiopulmonary exercise
cardiopulmonary exercise variables
cardiovascular complications
cardiovascular event rate
cardiovascular health
cardiovascular hospitalization
cardiovascular outcomes
cardiovascular risk factors
cardiovascular system
cardiovascularverter defibrillators
care management
carotid bodies
carotid intima-media
case-control study
caspase-3 activity
caspase-3 gene expression
catabolic/anabolic imbalance
catalytic
catheter ablation for af
catheter-based percutaneous revascularization
cav1.3 channels
cdp choline
centers for medicare and medicaid
centers for medicare and medicaid services demonstration
centrimag right ventricular assist device
centrimag rvad
cf devices
cf lvad patients
charm programme
chart review
chelation choices
chelation regimens
chemotherapy-induced heart failure
chf after hct
chf atrial explants
chf intubation rates
chf patients
chf predictive model
chf treatments
chf visit rates
chf-developed infarcted animals
chf-dnx
chf-inv
chf-inv group
chf-inv rabbits
childhood malignant disease treatment strategies
chinese herbal medicine
chm
chrmatin-associated proteins
chromatin remodeling events
chromatin-dependent signal transduction
chromatin-mediated signal transduction to pol ii
chronic advanced heart failure patients
chronic disease
chronic heart failure chronic heart failure
chronic heart failure induced
chronic hf-ref
chronic inflammatory state
chronic insulin exposure
chronic kidney disease epidemiology collaboration equation
chronic stable guideline-directed medical therapy
chronically instrumented new zealand white rabbits
ci=0.97-0.98)
circulating cd34
circulating fragments
circulating mediator
circulating nt-probnp
circulating nt-probnp concentration
circulating plasma ne
circulatory arrest
circulatory derangement
circumferential shortening
class i
class ii heart failure
class iii
clcnka gg genotype
clcnka polymorphism
clin
clinical benefit
clinical composite response
clinical diastolic dysfunction
clinical doppler echocardiography
clinical excellence registry
clinical modification codes
clinical outcome
clinical outcomes
clinical prediction rule
clinical status
clinical trial registries
clinical trials
cms metrics
cncka snp
co correlated
co-activating transcription factor networks
cochrane databases
cochrane effective practice
cognitive function
cognitive impairment
cohort
collagen density
colon
comanagement
commissie
community outpatient settings
compensatory hypertrophy to cardiac failure
competing priorities
competitive collateral
computed tomographic angiography
computing readmissions
concordance c statistics
concurrent hf
conditional gene-targeted hand2 mice
congenital abnormalities
congenital accessory pathways
congenital heart lesions
congestion-like
congestive heart failure exacerbation
congestive heart failure patients
congestive heart failure phenotypes
congestive heart failure trial
congestive heart failure visits
conscious
conscious dogs
conscious hf rats
conscious rabbits
consensus report
consenting ambulatory hf patients
contemporary heart failure
contemporary therapeutic options
content-driven telehealth system
content-driven telehealth technology
contrast agent
contrasting groups
control adenovirus
control group
controlled randomized trials
controlled trial investigating outcomes of exercise training
controlling heart rate
cost
cost-effectiveness
costs
cox model analysis
cox proportional hazards analyse
cpet guiding exercise rehabilitation
cpg recommendations
cpg-recommended pharmacological treatment
creatine kinase activity
crf distribution
cronbach
cross-sectional
crt group
crt implantation
crt off
crt on
crt on assignment
crt-d recipients
crude
crude 28-day case-fatality rate
crude rates
crude rr
cultured cardiomyocytes
cumulative urine volume
cv death
cv deaths
cv events
cxl-1020 contractility
cxl-1020 converts
cxl-1020)
cystatin c level
cytotoxic effect
danish heart failure database
dapc protein levels
dash diet
dash diet scores
dash/srd reduced clinic
deactivation
debilitating stroke
decongestion
decongestion end point
decoy vegf receptor
decrement
defibrillator-only therapy
depressed left ventricular
depresses
depression
depressive symptoms
deranged ca(2+) handling
derivation cohort
descriptive assessment
descriptive research
desensitizes against acute β-ar stimulation
design
detergent
development and evaluation
device
device consideration
device implantation
devices
diabetes status
diabetic zsf1 rats
diagnostic approaches
diagnostic performance
diagnostic procedure
dialysis patients
dialysis-dependent patients
diameter stenosis
diastolic indices
diastolic properties
diet
diet adherence
diet group
diet score components
dietary interventions
dietary recommendations
dietary sodium restriction
differential g-protein coupling
diffuse myocardial changes
dimension index
direct observation
direct renin inhibitors
disappearance
discharge patients
discrimination
disease management
disease management programs in heart failure
disease progression
disease recapitulates
diseased human
disturbed intestinal barrier
dithiothreitol
diuretic efficacy
diuretic peptides
diuretic refractory severe-end-stage hf
diuretic resistant volume overload
diuretic response
diuretic use
dodson et al
doppler early diastolic mitral annulus velocity
dose uptitration
doxorubicin cardiotoxicity
doxorubicin efflux transporter abcc2
doxorubicin in vitro
doxorubicin treatment
doxorubicin-induced heart failure
driveline infection
driveline injury
drs deciles
drs-stratified analyses
drs-stratified hazard ratios
drug abrogated
drug-free
drug-untreated failing hearts
dtt
duration
dynamic
e-lateral
e-septal
e-septal correlated
e/e
e/e'lateral
e/e'mean
e/elateral
e/emean
early diastolic mitral annular velocity
early medical management
early physician follow-up after discharge
early transmitral blood flow velocity over tissue
early transmitral flow
ec coupling
eccentric versus concentric left ventricular hypertrophy
ecct patients
ecg parameters
echo-doppler studies
echocardiographic assessment
echocardiographic evidence
echocardiographic examina
echocardiographic measurements
echocardiographic measures
echocardiographic predictors
echocardiographic score
echocardiography evaluations
ecmo group
ecmo+vad group
ecmo+vad groups
economic analysis
economic climate
economic impact
economische evaluations
economische models
ed patients
ed physicians
ed visits
ed volume
effects of care management
efficiency
egfr group ii
egfr group iii
egfr group iv
egs ratio
eh denotes
elastic n2 bus segment
elderly
electrocardiographic device
electromechanical behavior
electronic databases
elektrial activation
elevated left atrial pressure
elevated resistin
eligibility
embryonic gene programs
embryonic gene programs in heart failure
emd prolongation
emergency cardiac catheterization
emergency department (ed
emotional status
emotional stress
emphasis-hf study
end stage heart failure heart failure
end-stage congestive heart failure
end-tidal co2
endothelial repair
endothelial-protective effects
energie expenditure
energy deficit
english-language trials
enos-ser(1177
enos-thr
enrollment
enrollment period
epigenetic readers in cardiac biology
epithelial to mesenchymal transition markers
eplerenone in mild patients hospitalization
eplerenone post myocardial infarction heart failure efficacy
erasers
erc induced recovery/enhancement
erk1/2 molecular scaffolds
erk1/2 signalling
erythropoiesis-stimulating agent therapy
esc advocate
eseptal
et
et on hdl-mediated protective effects
ethically complex situations
etiologic causes
eu
eu/va/va-rt cohorts
europese retrospective cohort study
europese society of cardiology guidelines
evidence-based care in heart disease evaluated
exercise
exercise adherence
exercise and medical therapies to improve cardiac function
exercise duration
exercise group
exercise performance
exercise programmes
exercise training
exercise training on hrqol
exercise training response
exertion
exogenous variants
expenditure
expenditures
experimental hf
extending emd
external validity
extracorporeal membrane oxygenation membrane support
factors predicting survival
failing fontan
failing heart
failing hearts
fat
fat mass index
fatal
fiber/sheet orientation
figuur
figuur profiling
fit
fit men
fixed-rate atrial pacing
flow-mediated dilatation diameter
fluorescence resonance energy transfer-based assays
follow-up exercise capacity
follow-up measurement
follow-up medication
force generated
framingham heart study criteria
free-breathing pulse sequennce
full medicare coverage
full-length scn5a
function
function in vitro
functional class iii hf
functional class nyha ii-iii
functional decline
functional deficits
functional efficacy
furosemide dose
futility
g
g-protein-coupled receptor kinase-2
gating movement
gdmt-treated nyha functional class iii hf
gene expression profile gse9128
genomic reprogramming events
global longitudinal strain
global proteomics
glomerular filtration
gls outperformed left ventricular ejection fraction
gly16/ glu27 haplotype
glycolysis/gluconeogenesis
goal-directed lipid-lowering therapy
grading of recommendations assessment
gross income
gross national income per capita
guideline recommendations in heart failure
guideline-recommended drugs for heart failure
guideline-recommended medications
guideline-recommended treatment
guidelines-heart failure
h-dko mice
haard ratio
habc battery score
habc battery scores
haemodynamic stress
hand grip strength
hart enrolled patients
hdl function
hdl particles
hdl-induced no production
health behaviors
health care expenditures
health insurance
health per capita
health status
health system data partners
healthcare utilization
healthy cardiomyocytes
healthy control
healthy heart muscle cells
healthy volunteers
heart failure adherence
heart failure admission
heart failure aldosterone
heart failure clinic
heart failure cost-effectiveness model
heart failure discharges
heart failure disease management programs
heart failure guidelines
heart failure home
heart failure hospitalization
heart failure index
heart failure mice model
heart failure mortality
heart failure myocardial tissue
heart failure nurse practitioner
heart failure nurses
heart failure patients
heart failure prone to ventricular tachycardia
heart failure rats
heart failure risk
heart failure survey in israel
heart failure t1-mapping values
heart failure treatment
heart failure-related hospitalization
heart pathology
heart rate response
heart rate variation
heart t2
heart team
heart transplant recipients
heartmate ii exchange
heartmate ii insertion
heartmate ii lvad
heartware intl
helix-loop-helix
hemodynamic alterations
hemodynamic disorder
hemodynamic status
hemodynamically stable
hemodynamically unstable
hemoglobin levels
hepatic function
heterogenous improvement
hf admissions to acute hospitals
hf canine electromechanics
hf clinic outpatients
hf complicating ami
hf disappeared
hf enrolled in the heart failure
hf epidemiology
hf guidelines
hf hospital admissions
hf hospitalisations
hf hospitalization
hf hospitalizations
hf induced in mice via phenylephrine
hf model
hf mortality
hf mortality risk
hf pathogenesis
hf patient plasma
hf patients
hf prediction model
hf progression
hf rats
hf registry
hf remodeling aspects
hf risk
hf risk factors
hf risk prediction
hf studies
hf symptom
hf units
hf volume management
hf-action cohort
hf-induced remodeling
hf-related cachexia
hfpef patients
hfpsi model
hfvt
hg
hgb level
hhf
hierarchical regression models
high-fat diet
high-risk patient
high-risk patients
high-volume physicians
hnorm group
home telemonitoring
hoog-cost medicare fee-for-service beneficiaries
hoog-volume physicians
hospital days
hospital discharge
hospital quality improvement initiative
hospital rates
hospital volume
hospital volume groups
hospital-based programmes
hospitalisation for heart failure
hospitalisations for heart failure
hospitalization for heart failure
hospitalized heart failure
hospitalized hf
hospitalized older adults
hospitalized patients
hr dynamics
hr per kg/m(2)
hr variability/turbulence
hr=0.931
hr=1.02
hretn
hum-retn mice
hum-retn mice treated
human heart failure
human myocardial tissue
human rad q66p
human resistin
humanized male mice
humanized mouse model lacking murine resistin
humoral stimuli
hvad devices
hybrid system
i
i-meta-iodobenzylguanidine
i-mibg
i-mibg cardiac washout
i-mibg myocardial washout
icd patients
icd-hf patients
icu admission
icu mortality
idealized lv end-diastolic pressure
idiopathic dilated cardiomyopathy cohort
if inhibitor ivabradine trial
ii
iii
immunoreactive nt-probnp
impaired right ventricular pump function
implantable cardioverter defibrillator-crt
implantable cardioverter-defibrillator deactivation
implantable cardioverter-defibrillator deactivation preferences
implantable cardioverter-defibrillator device
implantable cardioverter-defibrillator therapy
implanted monitoring devices
in vivo inhibition
in vivo rv length-force relationship
in-trial resource utilization
inactive cxl-1051
inappropriate atp
inappropriate implantable cardioverter-defibrillator therapy
inappropriate shock therapy
inappropriate therapy
incessant ventricular tachycardia storm
incidence and mortality outcomes
incident cardiovascular events
incident hf
index
index admission
index ami
index beat method
index ed visit
inducible myocardial ischemia
industrial areas
infarct size
infarcted hearts
infarcted rats
inflammation-stimulated resistin levels
inflammatory abdominal problems
inflammatory biomarkers
inflammatory markers
inflammatory stimuli
ingenuity pathway
inhibit cardiac l-type channel activity
inhibiting tgf-β receptor type i
inhibition
inhibition of vascular endothelial growth factor
inhibitor jq1
inhibitors
inhibitory actions
inhospital mortality
inhospital outcomes
inimpaired lv relaxation
inmuscular testosterone supplementation
inoperable chronic thromboembolic pulmonary hypertension
inpatient admissions
inpatient assessments
inpatient medical conditions
inpatient records
inpatients with heart failure
insights from heart failure
insulin action
insulin products
insulin receptor substrates
insulin-signaling components regulating cellular metabolism
insulin-stimulated rates
intact hearts
interleukin receptor family member st2
intermediate frailty
intermediate metabolism
internal reliability
interne
interne consistency
interventions
interventricular septum biopsies
intestinal morphology
intolerance
intravenous atropine
intravenous inotropes
intravenous iron
intravenous metoprolol
intubation rates
invasive hemodynamic
invasive hemodynamic assessment
ip
iron
iron deficiency
iron-deficient adult patients
irs2 double-knockout
irs2 proteins
ischemic conditioning
ischemic etiology
ischemic heart failure samples
ischemic hf pathogenesis
isolated cardiomyocytes
isolated heart rate
isolated heart transplant
isolated heartmate ii
isolated heartmate ii lvad
isolated hr reduction
isoprenaline infusion
iv heart failure
iv hf
ivabradine group
ivabradine on exercise capacity
ivabradine unloads
japanese heart failure patients
joanna briggs institut
kansas city cardiomyopathy questionnaire summary
kccq category
kccq domains
kccq overall summary
kccq overall summary scores
kccq scales
kccq summary scores
kcl-ki treatment
kidney index score
kidney injury
kosten
kosten-effective
kv4.3 channel mrnas
kv4.3 mrna levels
kwh
l-dko mice
l-type ca2
l-type ca2(+) current amplitude
l-type channel isoforms
label-free shotgun proteomics
lack of hypertension
lad model
lad models
lager
lager exercise time
lancet
lcx model
leaflet configurations
leaflet motion
leaflet repair
lean zsf1
lean zsf1 group
left
left ventricular assist device implantation
left ventricular biopsies
left ventricular ejection
left ventricular filling pressure response to exercise
left ventricular function assessment
left ventricular longitudinal systolic strain
left ventricular mechanics
left ventricular midpapillary level
left ventricular tissue
left-hand grip strength
leg strength
length-force relationship
leu3-gly4
lf/hf ratio
liberal transfusion protocols
life score
life-sustaining treatment
limitation
literature
literature search
littermate controls
log2 ng/ml
logistic analysis
logistic regression models
lokomat® system
long-term clinical outcomes
long-term costs
long-term mortality
long-term survival
low crf categories
low left ventricular ejection fraction
low left ventricular ejection fractions
low testosterone status
low-dose bb
low-dose dopamine
low-dose nesiritide
low-frequenncy/high-frequenncy
low-volume ed cases
low-volume eds
low-volume physicians
lower body mass index
lower cd34+vegfr2+ cells
lower exercise performance
lower lvef
lower mortality
lp-pla2]
lung weight
lv end-diastolic pressure/wall stress
lv posterior wall thickness
lv structure
lv systolic indices
lvad implantation
lvad support
lvad surgery
lvas support
lvet carries prognostic value
lying
madit-crt trial
magnet(®
magnetically levitated centrifugal-flow chronic lvas
magnetically levitated left ventricular assist system
magnetically levitated rotor
main outcome
maladaptive cardiac remodelling
maladaptive molecular processes
maladaptive remodelling
male sex
males
malfunctioning heartmate ii lvads
malondialdehyde bound to hdl
management
management strategies
markers
maximal cardiopulmonary exercise test
maximum o2 consumption rate
mdc95%
mean
mean ejection fraction
measuring np levels
mechanical
mechanical dyssynchrony
mechanical support devices
mechanistic insight
median age
median baseline st2 level
median body mass index
median follow
median followup
median left ventricular ejection fraction
median rate ratio
medical management
medical outcomes
medical records
medical support
medical treatment guidelines
medicare fee-for-service
medicare fee-for-service beneficiaries
medicare hospital claims
medicare inpatient data
medication regimen
mediterranean
men
metabolic enzymes
metabolic risk factors
methodology
methods
metoprolol treatment
metric
metric choice
mi characteristics yielded hazard ratios
mi diagnosed
mi-induced decreases
microarray data
micrornas in heart failure
mid lad
mild mr
minnesota living with heart failure
mir-25 expression integrate
mitochondrial damage induced
mitochondrial oxidative phosphorylation
mitochondrial oxidative stress
mitochondrial proteome changes
mitochondrial ultrastructural
mitochondrial-targeted
mitochondrial-targeted antioxidant
mitochondrial-targeted peptide ss31
mitral filling flow volume
mitral stenosis reversed
ml/kg/min
ml/m2
mlhf
mlhf total score
model
moderate
modifiable risk factors
molecular biomarkers
molecular mechanism
monotype natriuretic peptide
morpholino-based knockdown
mortality risk
mortality/hospitalization
mouse heart
mouse heart failure
mouse hf model
mouse myocardium
mouse rad q65p
mouse tac model
mouse ventricular myocytes
mpsms database
mri-based models
mrna levels
mt
multicenter
multicenter automatic defibrillator implantation
multihospital study
multivariable cox modeling
murine equivalent
murine myocardium to heart failure
muscle strength
muscle strip stiffness
muscle strips
muscle-wasting syndrome
muscular strength
mutant mice overexpressing hand2
myocardial extracellular matrix accumulation
myocardial glycolysis
myocardial infarction-both
myocardial loss
myocardial pde2 expression
myocardial phosphodiesterase-2
myocardial titin hypophosphorylation
myocardium displays altered expression
myocyte diameter
myocyte hypertrophy antecedent to heart failure
myofiber shortening onset
myofiber shortening velocity
myofibrillar ca(2+)-stimulated atpase activity
myofilament ca(2+) sensitivity
myosin binding protein-c phosphorylation
n-
n-terminal fragment
n-terminal pro-brain-type natriuretic peptide assessment
na+ channel mrna splice variants
na+ channels activate unfolded protein response
nanomolar doses
national medicare data
natriuretic peptide levels
natriuretic peptide system
natural vasodilatory
nc
nc=235
negative coronary angiography
neonatal rat ventricular cardiomyocytes
neprilysin blocks renin-angiotensin-aldosteron
neprilysin inhibitor prodrug
net economic savings
net reclassification
network meta-analysis
neurohormonal abnormalities
neurohormonal activation
neurohormonally induced heart disease
neutral endopeptidase inhibitors
new york heart association class i to iii
new york heart association class i/ii fontan adults
new york heart association class ii to iv hf
new york heart association class iii heart failure
new york heart association classes i
nicorandil ameliorates mitochondrial dysfunction
nights spent in hospital
ninth revision
nitric oxide donors
nmol/l
no beta-blockers
noc outcomes
non-aas
non-diabetic patients
non-dnx
non-fatal stroke
non-frail participants
non-ischemic
non-ischemic heart failure samples
non-lbbb
non-linear hr variability
non-urbanized midwestern state
nonadherence
noncardiovascular diagnoses
noncardiovascular drugs
noncoding rnas
nondiabetes risk factors
nonfatal outcomes
nonpace
nonpace dnx
nonselective
nonsurvivors
nontraumatic death
nontreatment
nordic walking
norepinephrine-induced hypertrophic
normal geometry
northwest united states
np assessment
np levels
np measurement
nt-probnp assay targeting nonterminal epitopes
nt-probnp cutoff point
nt-probnp levels
nt-probnp testing
nuclear factor
nurse assessment
nursing terminologies
nursing-sensitive outcome
nursing-sensitive outcome change scores
nutrition
nutritional abnormalities
nutritional strategies
nuts
nyha functional assessment
nyha functional class ranking
obese older patients
obese participants
obese zsf1
obese zsf1 groups
odds ratio/hazard ratio
ods ratio
off-pump sternal sparing approach
oht bridged to transplant
older adults
onderzoek
open chest model
open stent
open-label crossover study
optimal diuretic therapy
oral glucocorticoid dosage
oral glucocorticoids
organisation of care taxonomy
overexpress scn5a variants
overstimulation
overweight
overweight body index strata
oxidative stress markers
oxygen consumption
oxygen flow
oxygen pulse
p = .006
p = 0.008)
p38alpha mapk
p38α mitogen-activated protein kinase
p<0.001
p=0.03
pace dnx
pace non-dnx
paco2 cerebral blood flow
paediatric cardiac transplants
paediatric heart failure
paf levels
paradigm shift
parasympathetic function
partial pressure
participatory
pasp increase
passive/stiffness
patent
pathobiology/pathophysiology
pathological gene expression
pathological gene induction
pathological heart disease
pathological hypertrophy
pathophysiological origin
patient compliance
patient consultation
patient management interventions
patient management interventions in heart failure cost-effectiveness model
patient preferences
patient safety
patient safety initiatives
patient satisfaction
patients hospitalized
patients hospitalized with heart failure
patients in heart failure
patients with heart failure
pay-for-performance
pb characteristics
pb cycle
pcwp estimation
pd initiation
pde superfamily
pde2 activity
pde2 overexpression
pde2)
pde2-mediated effects on beta-adrenergic receptor
pde2-overexpressing cardiomyocytes
peak o2 per kilogram
peak vo2)
pediatrc heart failure
pediatric heart failure
pediatrics
percutaneous coronary revascularization
percutaneous one-vesel model
performance
periprocedural
perk activation destabilized scn5a
perk inhibition
permeability
perturbed mitochondrial function
petco2)
pevk segment
pf cohort
pf mean
pf-cpt
pg/kg/min
pg/ml
pharmaceutically assisted
pharmacologic management
pharmacologic studies
pharmacologic therapies
pharmacologic treatment
pharmacological armamentarium
pharmacological treatment
phenylephrine-induced genes
phosphomimic ser77
physical exhaustion
physician adherence
physician adherence to hf cpgs
physician continuity
physician follow-up
physician volume
physicians busy
physiological proteolysis
pigs
pka subunits
pkc-βii-ser
placebo-controlled clinical trial
plasma collected
plasma samples
plasticity
pluripotency marker nanog
poc measurement
poc systems
poc technology
point-of-care systems
policy recommendations
poor myocardial function
poorer vo2 max
porcine model
positron emission tomography imaging
post-acute care transfer policy
post-dash/srd brachial
post-hct chf
post-lvad
post-myocardial infarction heart
post-myocardial infarction heart failure patients
post-myocardial infarction patients
post-transplant morbidity
posteriorly displaced papillary muscles
postmarketing trials
postmenopausal women
postnatal mammalian myocardium
postoperative echocardiography
postoperative mortality
postoperative normalization
postoperative survival
postystolic
practice settings
practice-level differences
practice-level variation
pre-crt lv
pre-hct exposure to anthracyclines
pre-hct germline dna
pre-pd
precipitating factor
prediction rule
predictor
predictors
preoperative albumin
preoperative clinical characteristics
preoperative demographics
preoperative hypoalbuminemia
preserved
preserved cardiac index
preserved ejection
preserved left ventricular
preserved systolic function
pressure development
pressure gradient
pressure-overload-induced hypertrophy
principal findings
prior stroke score
pro6-gly7
proangiogenic effects
proces redesign contextual framework
prognostic factors
prognostic meaning
prognostic power
programmed cell death
progression to heart failure
progressive disease
prolonged electromechanical delay
proof-principle cohort
propensity score decile
prostate
protective effects
protective peptides
protein content
protein levels
protocol-driven poc testing
province of alberta
proximal circumflex artery
proximal lad
proximal left anterior descending
proximal left anterior descending artery
ps
psoriasis patients
psychometric testing
psychosocial factors
public health
public reporting
pulmonar congestion
pulmonary arterial hypertension medication
pulmonary artery snared
pulmonary hypertension patients
pulse-wave velocity
pump exchanges
pump failure
pump malfunctions
pure epicatechin
pure hno donor to enhance myocardial function
pyridostigmine administration
quality
quality improvement database
quality measures
quality of care programme
quality of life assessment
quality-of-life score
quality-of-life scores
quantitative proteomics
québec randomized to rhythm
r-r interval oscillations
r. cluster analysis
race
rad on cav1.2
rad q65p attenuates
rad q66p
rad q66p limits
radial artery tonometry
radioenzymatic-
raised blood glucose levels
randomized trial
rapid right ventricular pacing
ras axis
ras-
ras-blocker uptitration
rat left ventricular
rate-control patients
rate-control strategies
rate-control treatment strategies
rats
rats enhanced pde2 expression
readmission metric
readmission metrics
readmission rate
readmission rates
readmission reduction program
readmissions in heart failure
receiver operating characteristic curve
recent findings
reclassification
recommended therapies registry
recreational athletes
reducd
reducd lv contractility
reducd mortality
reducing mortality
reference lists
refill compliance
refractory
regional circumferential strain
regulate expression
regulation of feeding
regulator of growth
regulatory subunit
relaxation/viscoelastic
relevant health service provision
religious beliefs
renal atherosclerotic lesions
replicating resource use
repolarization instability
repolarization lability
residual confounding
resistance training
resistin levels
resource use
response after cardiac resynchronization therapy
restrictive red blood cell transfusion strategy
resynchronization reverses remodeling
resynchronization-defibrillation
retention trial
reverse cardiac remodeling
reverse remodeling parameter
reversibility
reversible myocardial ischemia
rhythm
rhythm- and rate-control strategies
right atrium mass
risk
risk factors
risk for heart failure
risk for hospitalized heart failure
risk of death
risk of heart failure
risk of hospitalization
risk of long-term mortality
risk reduction
risk stratification models
risk-adjusted all-cause mortality
risk-adjusted mortality
rm strategies
rm trended to reduce all-cause mortality
rna polymerase ii
robot-assisted gait therapy
robot-assisted training
rr intervals
rv function evaluation
s1pr1 downregulation
s1pr1)
s1pr1) reciprocal downregulation
sa in predicting adverse cv events
saf cohort
safety end point
sampling frame
sarcomere length relations
sarcomere shortening
saxagliptin users
schfi
sci
scientific literature
scn5a electric remodeling
scn5a transcript
scn5a variants
score
sd testosterone levels
sdqt to sd
sdqt-to-sdrr ratio
segment-elevation mis
self-care
self-care confidence scale
self-care education
self-care maintenance scale
self-care management scale
self-care of heart failure index
septal defect
septal wall cs
septum (systolic) thickness
sequential phosphorylation
ser23/24 troponin i phosphorylation
ser83 mutant riα proteins
ser83 phosphorylation
serial evaluation
serum albumin levels
serum creatinine level
serum factors
serum potassium level
serum resistin levels
severe ai
severe cad
severe end-stage hf
severe hyperkalemia
severe hypertension
severe hyponatremia
severely reduced lvef
sex
sham
sham levels
sham-dnx
sham-innervated
sham-inv
sham-operated
sham-operated animals
short-form quality of life domains
shotgun lc-ms
shunt implants
signal transduction cascade
signalling cascades integrate
simulations
sitagliptin users
skeletal muscle abnormalities
skeletal muscle mass
skeletal muscle mass assessed
skeletal muscle mass correlated
skeletal muscle sarcomere structure
skinfold thickness
skm biopsies
skm growth/differentiation
skm mitochondrial structure
slowed conduction
small gtpase rac1 activity
small-molecule inhibitors
smoked
smoking
smoking cessation
snp rs10927887
social mandate
social support
sociale support
sodium-restricted dash diet
sodium-restricted dietary approaches to stop hypertension diet
soluble (s)st2
soluble guanylate cyclase
soluble st2 in ambulatory patients
southeastern minnesota residents
sphingosine-1-phosphate receptor
spironolactone dose
sprague- dawley rats
sr ca(2+)-pump function
sst2 concentrations
sst2 measurement
sst2 status
sst2 titrated to high-dose bb
sst2/high-dose bb
sst2/low-dose bb
st2 levels
stabilized chronic heart failure
stable heart failure patients
stable hfpef
stage i-iii breast cancer
standard cardiac rehabilitation
standard care
standard heart failure medicines
standing blood pressure
statitistical significance
ste analysis
stent coated with a polytetrafluoroethylene tube
strain rate
stress conditions
stretch rate
stroke prevention trial
sts hh
sts hm
study closure
study design
subcellular alterations
subclinical atherosclerosis
sudden cardiac death
sudden cardiac deaths
surgical conditions
surgical method of transverse aortic constriction
surgical patients
surgical revascularization
surgical ring implantation
surgical tactics
survival
survival study
survival study in heart failure
sustainability
svr index
swedish national inpatient registry
swedish web-system for enhancement and development
swine
swine model
sympathetic control
symptom limited maximal cpet
symptomatic chronic advanced heart failure patients
systematic review
systemic/uv treatment
systolic heart failure treatment
systolic human heart failure
systolic left v entricular dysfunction
t1 changes
t1-mapping sequence
t1-mapping technique
t1-mapping values
t2d consumed erc
tac surgery
tac-
tac-induced heart failure
tac-induced proteomic alterations
tachy-
tachycardia-induced heart failure
tachycardic response
tapse vs pasp relationship
tapse-to-pasp ratio
tapse/pasp
target genes
taxonomy
technical advisors
techniek
tertiary referral centre
test-retest reliability
testosterone group
tgf-β inhibition
thalassaemia
therapeutic functions
therapeutic interruption
therapeutic left-to-right interatrial shunting
therapeutic strategy
therapeutic targets
therapeutic treatments
therapy refractory cardiogenic shock
thirty-day mortality
time domain heart rate variability
time to esrd
time-dependent covariates
tissue
tissue doppler imaging
tissuefaxs technology
titin isoforms
titin modification
tm interventions
tnfα
to death
tobacco
total adiponectin
total cholesterol
total symptom domains
toxicity
traditional heart failure
trans
transcription
transcription factor dhand
transcription factor hand2 in heart failure
transforming growth factor beta-dependent yield
transfusion thresholds
transgenic for the human retn gene
transitions of care program
transmitral e-wave/early diastolic mitral annular velocity
transmitral flow velocities
transplant ineligible patients
transplant pool
transplant-ineligible patients
transplantation eligibility status
transplantation to consultation
trastuzumab use
trastuzumab-related cardiotoxicity
trastuzumab-related chf
trastuzumab-treated patients
trastuzumb-related chf
treadmill exercise testing
treadmill testing
treating advanced hf
treatment
treatment for heart failure
treatments
trial-cardiac resynchronization therapy
trials
trichrome blue histologic
trigger hemoglobin threshold
trpm7) channel mrna
tta/tetmena
tta/tgtetmena mice
tta/ttetmena mice
tunel assay
twist
two-vessel disease model
type ii regulatory
unclear etiology
uncontrolled hypertension
underlying heart disease
undiagnosed heart disease
undirectional left-to-right interatrial shunting
unfavorable outcome
unfit
unfit men
unilateral
unit costs
university of michigan hf clinic
unloading
unplanned readmission
untranslated region
upr effectors
urgent cardiac transplant
urgent readmission
v end-diastolic volume
va cohort
va-rt cohort
vad group
vad groups
vagal
vascular endothelial growth factor protein
vasodilator effects
vasopressin receptor antagonist therapy
vd
vegetables
vegf inhibition counteracted
vegfr2
vehicle
velocity
velocity time integral
ven/ vco2 slope
ventricle overload
ventricular action potential duration
ventricular assist device implantation
ventricular assist device support
ventricular contractile reserve
ventricular dilatation
ventricular ejection
ventricular ejection fraction
ventricular power index
ventricular pressure overload
ventricular structure
ventricular systolic
ventricular systolic hf tissue samples
ventricular wall stress
ventricular-pulmonary arterial coupling
ventricularly paced
verficacy outcome
veterans
vh
virtual cohorts
voltage-gated ca(2+) channels
voltage-gated cardiac na+ channel α-subunit
voordelen
vvd variations
wasting
weak grip strength
weight
weight loss
western australian linked administrative health data
western blot analysis
white
whole grain intake
wilcoxon
wild type
wild-type littermates
willebrand factor
wind association
wind cohort
women
womens health initiative
work load-corrected chronotropic response
world health organization website
wrf
writer
wstar-kyoto
wt
xo-mediated ros effects
yorkshire swine
young woman
zebrafish
zsf1 groups
zsf1 rats
zung
β-ar drive
β-ar stimulation
β-ar stimulation via catecholamine infusions
β-blocker dose
β-blocker metoprolol
β-blocker uptitration
β-blocker uptitrations
β-blocker-induced enhancement
β2-receptor haplotype status
